COMMUNIQUÉS West-GlobeNewswire

Vor Bio Announces $55.6 Million Private Placement
27/12/2024
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33 ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with Mylotarg in the second [...]
Outlook Therapeutics® Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update
27/12/2024
LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK); First commercial launch anticipated in H1 CY25 Received [...]
WEED Inc. President and CEO Releases Letter to Shareholders
27/12/2024
TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – WEED Inc. (OTCQB: BUDZ ) , (“WEED,” “HEMP” or the “Company”), a global cannabis and hemp bioresearch company based in the U.S., shares the Company’s 2025 plans [...]
Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split
27/12/2024
STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “ Company ”), today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock and reduction in [...]
argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy
27/12/2024
VYVDURA ® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx's VYVGART ® and VYVDURA portfolio approved in Japan for three indications – first country globally with [...]
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
27/12/2024
Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance [...]
Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives
26/12/2024
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact [...]
Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference
26/12/2024
The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators [...]
Recover Red Introduces Portable Red Light Therapy Solution: The Power Stack
26/12/2024
Portable, Travel-Friendly Device That Includes Everything You Need For On-The-Go Red Light Therapy. All Neatly Packed Into A Compact 12-Inch Travel Case PITTSBURGH, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The widespread [...]
TOMI Environmental Solutions Announces Additional CES Installation at a Pharmaceutical Facility in the UK
26/12/2024
FREDERICK, Md., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announced today another [...]
Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide
26/12/2024
Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to announce the significant achievements of its IsoPet ® Animal Cancer Division, setting new milestones in veterinary cancer care, and [...]
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B
26/12/2024
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed – – In the first 150 mg dose cohort, ABI-4334 showed strong antiviral activity with a mean reduction [...]
Optinose Announces 1-for-15 Reverse Stock Split
26/12/2024
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN) , a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it will [...]
TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium
26/12/2024
WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies [...]
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
26/12/2024
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: [...]
SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation
26/12/2024
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors Ltd., (“AutoMax”), a leading automotive importer and distributor in Israel with [...]
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
25/12/2024
Company announcement – No. 53 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, [...]
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
25/12/2024
Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, 25 December 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 [...]
CorVel Announces Effectiveness of Three-For-One Forward Stock Split
24/12/2024
FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced the effectiveness of a three-for-one forward stock split, along with a proportionate increase in the number of [...]

Pages